Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis
Carmustine wafers (CW; Gliadel® wafers) are approved to treat newly-diagnosed high-grade glioma (HGG) and recurrent glioblastoma. Widespread use has been limited for several reasons, including concern that their use may preclude enrollment in subsequent clinical trials due to uncertainty about confo...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer US
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368843/ |